The general position
Being on an antidepressant does not by itself prevent you from driving in Australia. Austroads medical standards focus on symptoms and functional impairment rather than diagnosis or medication class. Most people on antidepressants drive without any licensing implications.
Situations that may affect driving fitness
Sedation from a specific medication may matter if it significantly affects reaction time. Recent suicide attempts, uncontrolled symptoms significantly affecting concentration or judgement, and recent hospitalisation for a serious mental health episode may also affect fitness to drive. In these situations, a medical assessment through your prescriber may be required before continuing to drive.
Practical guidance
In the first one to two weeks of a new antidepressant, avoid driving if you notice significant drowsiness or dizziness. Read more about managing antidepressant fatigue. Once side effects settle, typically by week three, most patients drive normally. If your prescriber has concerns about driving safety, they will advise you directly. If you drive commercially, disclosure requirements may differ; check with your prescriber and licensing authority.
What to flag to your prescriber
Raise these at any review
- Significant drowsiness or reaction-time changes that affect driving safety.
- Any incident or near-miss you attribute to medication effects.
- Prescriber advice against driving temporarily.
- Commercial driving requirements you are unsure about.
Frequently asked questions
Do I need to tell the licensing authority I am on an antidepressant?
For personal driving in most Australian states, no. Antidepressant treatment does not by itself require disclosure. Commercial licensing may differ.
Can I drive while adjusting to a new antidepressant?
In the first one to two weeks, avoid driving if you notice significant drowsiness or dizziness. Most people return to normal driving by week three.
What if my prescriber says I should not drive?
Follow that advice. Prescribers advise against driving only when there is a specific safety concern.
Evidence and sources referenced
- NICE Guideline NG222 — Depression in adults: treatment and management (United Kingdom).
- Royal Australian and New Zealand College of Psychiatrists (RANZCP) — Clinical Practice Guidelines for Mood Disorders.
- NPS MedicineWise — prescriber and patient resources on antidepressant treatment (Australia).
- Royal College of Psychiatrists — patient information on antidepressants.
- TGA and FDA — product information for SSRI and SNRI medication classes.
- Maudsley Prescribing Guidelines in Psychiatry — prescribing patterns and side-effect timelines.
Related reading
Keep a calmer record of the first 90 days
If you want a calmer way to keep a short daily record across the first 90 days, Causiq is being built for exactly that.
Join the waitlist